Stents are used to treat patients with coronary artery disease who experience decreased coronary blood flow. However, stents can promote the absorption of fibrinogen, resulting in platelet aggregation. This can provoke an inflammatory response, which delays healing and promotes the formation of a fibrin mesh, leading to thrombus formation.

This animation shows how XIENCE, which is coated with a fluropolymer, is safer and more effective than other stents. XIENCE promotes the adhesion of albumin, which displaces other thrombogenic proteins and forms a protective layer. This decreases the inflammatory response, reducing the likelihood of thrombus formation and promotes healing following stent implantation.

Are you interested in seeing how our award-winning medical animation can help you?

Random42 constantly strives to innovate in the medical animation space. Get in touch for a consultation on your next project.


GSK Random42 client

‘‘For experts, there’s limited time in which they will interact with this content, so getting a message across quickly is crucial, and this medium does it very well.
Product Manager, GSK

BMS logo Random42 client

‘‘Their turnaround time sets them apart from the rest of the field. The fact they can turnaround lots of comments in a couple of days is impressive, whereas that took weeks with other agencies we worked with. They’re well above the benchmark.
Oncology Clinical Liaison, Bristol-Myers Squibb

‘‘It was a combination equally of quality of work but also the comfort and confidence that I knew I would be working with PhDs. They gave me the confidence that they would have the ability to understand. The other companies didn’t have those sorts of people on staff, they were just good animators. That was the area where I felt that I could trust Random42 would deliver.’’
Senior Product Manager, Spectranetics

Amgen Logo

‘‘I have been to a lot of conferences and I have seen a lot of videos both from competitors and internally – in my eyes it is night and day. The quality Random42 have is not one step ahead, it is far ahead compared to what I have seen before.’’
Product Manager, Amgen